Randomized Amifostine For SCCHN

Clinical trial NCT00095927 · COMPLETED

Trial details

NCT number: NCT00095927
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapeutic Agent Toxicity Head and Neck Cancer Mucositis Radiation Toxicity Xerostomia

Start date: 2003-05-01
Primary completion: 2007-06-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.